enamel matrix derivative

Animal productexperimental

In dentistry, enamel matrix derivative (EMD) is an extract of porcine fetal tooth material used to biomimetically stimulate the soft and hard tissues surrounding teeth to regrow following tissue destruction. — Wikipedia

Clinical trial activity

6 trials · 6 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
2

Earliest trial started Jun 1, 2002 (NCT02195765)

Timeline

No events for the selected filters.

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • enamel matrix derivative

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06725095N/ADec 5, 2024University of Catania
NCT02972788N/AJan 1, 2017University of Nebraska
NCT02907528N/AJan 1, 2014Ohio State University, University of Campinas
NCT02474498Phase 4Mar 1, 2013University of Campinas
NCT02218515Phase 4Sep 1, 2010Marmara University
NCT02195765N/AJun 1, 2002University of Sao Paulo
Showing 6 of 6 trials
Page 1 / 1

Organizations

Research & Development (6)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
University of CampinasAcademic/Hospital2122013
Marmara UniversityAcademic/Hospital1112010
Ohio State UniversityAcademic/Hospital1112014
University of CataniaAcademic/Hospital1112024
University of NebraskaAcademic/Hospital1112017
University of Sao PauloAcademic/Hospital1112002
6 organizations
Page 1 / 1